About Dales Laboratories P Ltd
Data last updated:
Dales Laboratories P Ltd is a private limited company based in Mumbai, Maharashtra, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 30 May 1983 and has been in existence for over 43 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1983PTC030091. Its GSTIN is 27AAACD5729N1ZA (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4.97 Lakh. It is led by directors including Bernard Anacleth Remedios and Vinayak Subhash Mulgaonkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.13 Cr, a decline of 14% compared to the previous year. For the same year it recorded a net profit of ₹18.56 Lakh (net margin 4.5%) and EBITDA of ₹27.39 Lakh (EBITDA margin 6.6%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 11% over five years.
As per MCA filings, the company has open charges of ₹20 Lakh and satisfied charges of ₹1.21 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dalesremedies.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address101 Abhishek Dalia Industrial Estate Off. Link Road Opp. Sab Tv Bldg. Andher, I (West), Mumbai, Maharashtra, India – 400058
- IndustryChemicals and Materials, Industrial Chemicals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Dales Laboratories P Ltd
The main business activity of Dales Laboratories P is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Dales Laboratories P Ltd FY 2025 filings available
Dales Laboratories P Ltd reported revenue of ₹4.13 Cr (down 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Dales Laboratories P Ltd
Revenue fell 14% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 11%. EBITDA fell 73% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Dales Laboratories P Ltd
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹27.39 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹18.56 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Dales Laboratories P Ltd
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dales Laboratories P are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Dales Laboratories P Ltd
Dales Laboratories P Ltd is compared with the companies closest to it by revenue in the Chemicals industry (Formulations, Industrial Chemicals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vivrthi Labs Private Limited | ₹4.14 Cr (FY 2024) | •••• | •••• | -6.0% | •••• | Hyderabad, Telangana, India |
| Rus-Med Exports Private Limited | ₹4.13 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | Mumbai, Maharashtra, India |
| Adar Chemicals Pvt Ltd | ₹4.13 Cr (FY 2025) | •••• | •••• | 47.0% | •••• | Vadodara, Gujarat, India |
| Param Medical System Private Limited | ₹4.13 Cr (FY 2025) | •••• | •••• | 34.0% | •••• | Ranchi, Jharkhand, India |
| Viechemie Skicorp Technology Solutions Private Limited | ₹4.13 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Kolkata, West Bengal, India |
| Dales Laboratories P Ltd this company | ₹4.13 Cr (FY 2025) | •••• | •••• | -14.0% | •••• | Mumbai, Maharashtra, India |
| Cellgen Biopharma Private Limited | ₹4.12 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | New Delhi, Delhi, India |
| Elegant Drugs Private Limited | ₹4.12 Cr (FY 2025) | •••• | •••• | 89.0% | •••• | Hubli, Karnataka, India |
| Ipm Bio Control Labs Private Limited | ₹4.12 Cr (FY 2025) | •••• | •••• | -12.0% | •••• | Hyderabad, Telangana, India |
| Lexicare Pharma Private Limited | ₹4.11 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Ankleshwar, Gujarat, India |
| MSR Pharmaceuticals Private Limited | ₹4.11 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Patna, Bihar, India |
Peers are the five companies nearest above and the five nearest below Dales Laboratories P by revenue in the Chemicals industry (Formulations, Industrial Chemicals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Dales Laboratories P Ltd
Dales Laboratories P Ltd is audited by Mahesh Chandra & Associates for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Mahesh Chandra & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Dales Laboratories P Ltd
Dales Laboratories P has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bernard Anacleth Remedios | Director | 30 May 1983 | 43 Years 4 Months | Current |
| Vinayak Subhash Mulgaonkar | Director | 10 Dec 2014 | 11 Years 9 Months | Current |
| Sabina Lawrence Fernandes | Director | 14 Feb 2009 | 17 Years 7 Months | Current |
Ownership and Shareholding of Dales Laboratories P Ltd
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dales Laboratories P Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Aug 2010 | Bank of Maharashtra | ₹22 Lakh | Satisfied |
| 20 Aug 2010 | Bank of Maharashtra | ₹22 Lakh | Satisfied |
| 22 Mar 2006 | Bank of Maharashtra | ₹15 Lakh | Satisfied |
| 21 Mar 2006 | Bank of Maharashtra | ₹62 Lakh | Satisfied |
Total charge records: 4 View all charges
Legal Cases of Dales Laboratories P Ltd
Dales Laboratories P Ltd has 1 court case on record: 1 filed by Dales Laboratories P. All case is disposed. Status as checked on 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Writ petition | Filed by the company against Union of India | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Dales Laboratories P Ltd
Dales Laboratories P Ltd has 4 MSME Form 1 returns on record between 2019 and 2023, listing 24 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 5)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| Sheth Impression LLP | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Nikeon Corporation | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 4 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Dales Laboratories P Ltd
Employment history and EPFO contributions of people linked to Dales Laboratories P.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Dales Laboratories P Ltd
Dales Laboratories P Ltd has 6 board changes on record since 1983: 3 appointments and 3 cessations. The latest: Vinayak Subhash Mulgaonkar ceased to be Additional Director on 30 Nov 2015.
5 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Dales Laboratories P Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dales Laboratories P Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dales Laboratories P Ltd
Dales Laboratories P has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACD5729N1ZA | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dales Laboratories P Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dales Laboratories P Ltd
Dales Laboratories P is an active private limited company based in Mumbai, Maharashtra, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 30 May 1983 (43+ years old) and is registered under CIN U24239MH1983PTC030091.
Dales Laboratories P reported revenue of ₹4.13 Cr for FY 2025 (down 14% YoY).
Dales Laboratories P has 3 current directors:
- Bernard Anacleth Remedios - Director
- Vinayak Subhash Mulgaonkar - Director
- Sabina Lawrence Fernandes - Director
Dales Laboratories P reported a net profit of ₹18.56 Lakh (net margin 4.5%) and EBITDA of ₹27.39 Lakh (EBITDA margin 6.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Dales Laboratories P is 10% over three years and 11% over five years. In the latest year (FY 2025) revenue fell 14%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Dales Laboratories P is 27AAACD5729N1ZA, registered in Maharashtra.
The CIN (Corporate Identification Number) of Dales Laboratories P is U24239MH1983PTC030091. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dales Laboratories P has 1 court case on record: 1 filed by the company.
Dales Laboratories P was incorporated on 30 May 1983, making it 43+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Dales Laboratories P by revenue are Vivrthi Labs Private Limited, Rus-Med Exports Private Limited, Adar Chemicals Pvt Ltd, Param Medical System Private Limited, Viechemie Skicorp Technology Solutions Private Limited and 5 more, all in the Chemicals industry (Formulations, Industrial Chemicals).
Vinayak Subhash Mulgaonkar ceased to be Additional Director on 30 Nov 2015. Vinayak Subhash Mulgaonkar was appointed as Director on 10 Dec 2014. Subhash Mulgaonkar ceased to be Director on 15 Sep 2014. Dales Laboratories P has 6 board changes on record in total.
Dales Laboratories P has 4 MSME Form 1 returns on record between 2019 and 2023, listing 24 overdue payments to 5 micro and small suppliers. The latest return was filed on 27 Apr 2023.